ELAB | Elevai Labs, Inc. Common Stock Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	1.6648 - 1.8455
52 Week Range	1.6100 - 176.00
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	1,139,417
Average Volume	2,712,864
Shares Outstanding	3,072,857
Market Cap	5,346,771
Sector	Healthcare
Industry	Biotechnology
IPO Date	N/A

Valuation
Profitability
Growth
Health
P/E Ratio	-0.02
Forward P/E Ratio	N/A
EPS	-88.92
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	18
Country	USA

Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.

*Chart delayed

Analyzing fundamentals for ELAB we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see ELAB Fundamentals page.

Watching at ELAB technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on ELAB Technicals page.